MF
Mehernosh Framroze Daruwalla
About Mehernosh Framroze Daruwalla
Mehernosh Framroze Daruwalla has 20 years in corporate governance. Holds Director and Additional Director roles. Currently with 1 company, including Lotus Surgical Specialities Private Limited and Nivian Life Sciences Private Limited. Formerly with 2 companies, such as Ti Medical Private Limited. Engaged in General Business. Contributes to corporate operations.
Current companies
| Company | Designation | Appointment | Founded | Status |
|---|---|---|---|---|
Nivian Life Sciences Private Limited
U21001MH2024PTC421643
|
Additional Director | 13 Aug 2024 | 2024 | Active |
Previous companies
| Company | Designation | Appointment | Founded | Status |
|---|---|---|---|---|
Ti Medical Private Limited
U33110TN2005PTC186177
|
Managing Director | 21 Oct 2005 | 2005 | Active |
Lotus Surgical Specialities Private Limited
U74120MH2013PTC240122
|
Director | 01 Feb 2013 | 2013 | Amalgamated |
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Mehernosh Framroze Daruwalla
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Mehernosh Framroze Daruwalla
Mehernosh Framroze Daruwalla has 20 years in corporate governance. Holds Director and Additional Director roles. Currently with 1 company, including Lotus Surgical Specialities Private Limited and Nivian Life Sciences Private Limited. Formerly with 2 companies, such as Ti Medical Private Limited. Engaged in General Business. Contributes to corporate operations.
Mehernosh Framroze Daruwalla is associated with 1 company as Director and Additional Director.
Mehernosh Framroze Daruwalla has expertise in General Business.
Mehernosh Framroze Daruwalla has 20 years in corporate governance.